Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small-cell lung cancer  by Takizawa, Tsuneyo et al.
MEDIASTINAL LYMPH NODE METASTASIS IN PATIENTS WITH CLINICAL STAGE I 
PERIPHERAL NON-SMALL-CELL LUNG CANCER 
Tsuneyo Takizawa, MD a 
Masanori Terashima, MD a 
Teruaki Koike, MD a 
Hideki Akamatsu, MD a 
Yuzo Kurita, MD b 
Akira Yokoyama, MD b 
Our aim in this study was to determine the mediastinal areas where 
lymphadenectomy should be done at the time of surgical resection of 
clinical stage I lung cancer. Between 1984 and 1994, 575 patients with 
clinical stage I non-small-cell lung cancer underwent lobectomy and 
systematic mediastinal ymphadenectomy. Mediastinal lymph nodes were 
pathologically positive for disease in 79 patients (14%), and positive nodes 
appeared normal intraoperatively in 54 patients (68%). Thirty-three per- 
cent of those patients with positive N2 (mediastinal) nodes had negative 
lobar (N1) nodes. In cancer of the right upper lobe, all N2 cases had the 
lymph node metastases in the superior mediastinal compartment. In cancer 
of the right middle lobe, all N2 cases but one had the metastases in 
subcarinal or anterior mediastinal nodes. In cancer of the right lower lobe, 
all N2 cases but one had the metastases in subcarinal nodes. In cancer of 
the left upper lobe, all N2 cases had the lymph node metastases in the 
subaortic compartment. In cancer of the left lower lobe, all N2 cases but one 
had the lymph node metastases in the subcarinal area or subaortic 
compartment. In conclusion, systematic staging of mediastinal lymph 
nodes is necessary for all patients with resectable clinical stage I lung 
cancer. The location of the primary tumor determines the mediastinal areas 
where lymphadenectomy should be done to examine all lymph nodes. 
(J Thorac Cardiovasc Surg 1997;113:248-52) 
A l though the negative predictive accuracy for me- diastinal ymph node metastasis with the use of 
computed tomography is high, l' 2 a few cases of N2 
disease occur among clinical stage I, or clinical NO, 
tumors. Whereas some authors claim that a radical 
systematic lymphadenectomy in the mediastinum 
should be the surgical procedure of choice for all 
patients with resectable lung cancer, 34 others rec- 
ommend sampling of  lymph nodes in the mediasti- 
num.6, 7 The extent of lymphadenectomy in the 
mediastinum is still a matter of controversy. In this 
study, we investigated the surgeon's intraoperative 
observation of lymph nodes and the stations of 
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diseased lymph nodes in patients with clinical stage 
I peripheral non-small-cell ung cancer (NSCLC). 
Patients and methods 
Between January 1984 and December 1994, 575 pa- 
tients with clinical stage I peripheral NSCLC underwent 
lobectomy and systematic mediastinal lymphadenectomy 
at the Department of Thoracic Surgery of Niigata Cancer 
Center Hospital; these patients formed the study group 
for this investigation (Table I). Each patient underwent 
assessment by plain chest roentgenography, bronchos- 
copy, computed tomographic scan of the thorax and 
abdomen, and bone scan. The tumor was not visible by 
bronchoscopy. Bronchoscopic peripheral biopsy or needle 
aspiration cytologic testing was done to determine the 
malignancy and histologic type of the cancer. Mediastinal 
and hilar lymph nodes were measured through a com- 
puted tomographic scan of the thorax. Lymph nodes that 
were 1 cm or less in short-axis diameter were considered 
normal. Mediastinoscopy was not used. 
Clinical stage I peripheral NSCLC was diagnosed pre- 
operatively in all patients. For the assessment of func- 
tional operability, spirography and blood gas analysis were 
done before operation. Patients in whom the tumor was 
classified as small-cell ung cancer after operation were 
excluded. Patients with double primary tumors were also 
excluded. Patients with minimal pleural invasion were 
included as patients with T3 disease. 
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Table I. Patient characteristics (n = 575) 
No. % 
Sex 
Male 322 56 
Female 253 44 
Age (yr) 
Median 65 
Range 29-83 
Histologie type 
Adenocarcinoma 432 75 
Squamous cell 124 22 
Others 19 3 
Cancer location 
Right 
Upper 163 28 
Middle 53 9 
Lower 122 21 
Left 
Upper 142 25 
Lower 95 17 
T stage 
T1 324 56 
T2 235 41 
T3 16 3 
N stage 
NO 446 77 
N1 50 9 
N2 79 14 
Surgical technique. The surgical approach was by pos- 
terolateral thoracotomy in the fourth or fifth intercostal 
space. The primary lung tumor was resected by lobectomy. 
The segmental (station 13) and lobar (station 12) lymph 
nodes were resected with the completion of lobectomy. 
The interlobar (station 11) lymph nodes and hilar (station 
10) nodes were resected before systematic mediastinal 
lymphadenectomy. 
Systematic mediastinal lymphadenectomy was done as 
described by Naruke, Suemasu, and Ishikawa. 4 The azygos 
vein was usually ligated and cut off to open the superior 
mediastinal compartment. The superior mediastinal (sta- 
tions 1 to 4) nodes between the trachea nd the superior 
vena cava were dissected from the level of the right 
subclavian artery to the azygos vein so that the trachea, 
superior vena cava, and ascending aorta were completely 
freed from all tissue. The subcarinal (station 7) nodes 
were removed in all patients. The paraesophageal (station 
8) and inferior pulmonary (station 9) nodes were routinely 
included in the dissection in patients with cancer of the 
lower lobe. The mediastinum anterior to the superior 
vena cava (station 3a) was not always dissected. In cancer 
of the left side, the subaortic ompartment lying between 
the phrenic nerve, the aortic arch, the left pulmonary 
artery, and the recurrent nerve to the level of the lower 
trachea (stations 4 to 6) was dissected. 
Lobectomy with systematic mediastinal lymphadenec- 
tomy was done as completely as possible if the surgeon 
detected hilar or mediastinal lymph node metastases. The 
Table II. Characteristics of patients with N2 disease 
(n=79) 
No. % 
Sex 
Male 42 53 
Female 37 47 
Age (yr) 
Median 65 
Range 29-78 
Histologie type 
Adenocarcinoma 63 80 
Squamous cell 12 15 
Others 4 5 
Cancer location 
Right 
Upper 20 25 
Middle 6 8 
Lower 17 22 
Left 
Upper 23 29 
Lower 13 16 
T stage 
T1 28 36 
T2 43 54 
T3 8 10 
surgeon reported the intraoperative detection of lymph 
node metastases immediately after the operation. 
Pathologic analysis. All lymph nodes were arranged by 
the surgeon according to the mapping of the American 
Thoracic Society. 8Each lymph node was examined patho- 
logically and classified as positive or negative for tumor. 
Results 
There were 79 patients with N2 disease (Table II). 
Data for 20 cases with mediastinal lymph node 
metastases from cancer of  the right upper lobe are 
shown in Table I lL The surgeon could not detect he 
lymph node metastasis in 16 cases. Eight cases were 
without a nodal metastasis in the lobar or hilar area 
(cases 1, 4 through 8, 12, 16). All cases had lymph 
node metastases in the superior mediastinal com- 
partment. Pretracheal (station 3) nodes had the 
most metastases of  all nodes. Subcarinal lymph node 
metastases were present in one case with bulky 
nodal metastases (case 19). 
Data for six cases with mediastinal lymph node 
metastases from cancer of the right middle lobe are 
shown in Table IV. The surgeon could not detect he 
lymph node metastasis in five cases. Four cases were 
without nodal metastases in the lobar or hilar area 
(cases 1, 3, 4, 6). Five cases had lymph node 
metastases in the subcarinal or anterior mediastinal 
area (station 3a). Lymph node metastasis in the 
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Table III. Mediastinal lymph node metastases from 
cancer of the right upper lobe 
Lymph node station? 
Case T Detection* 3a 1 2 3 4 7 10 11 12 13 
1 2 No 1 
2 2 No 1 2 
3 2 Yes 1 1 
4 2 No 2 
5 3 No 1 
6 3 No 1 
7 1 Yes 1 
8 2 No 1 
9 2 No 1 1 
10 2 No 1 2 
11 1 No 1 1 1 1 1 
12 2 No 2 
13 3 No 2 1 
14 2 Yes 3 4 1 1 
15 3 No 1 1 1 
16 2 Yes 3 1 
17 2 No 1 1 
18 2 No 2 1 1 1 1 
19 2 No 1 1 1 1 3 2 1 1 
20 3 No 1 1 1 3 1 1 1 
*Yes indicates that the surgeon could detect he lymph node metastasis 
intraoperatively; no indicates that he or she could not. 
tLymph node stations are numbers according to the American Thoracic 
Society? Station 3a is the mediastinal rea anterior to the superior vena 
cava. A figure in the column of lymph node station is the number of 
metastatic lymph nodes. 
Table IV. Mediastinal lymph node metastases from 
cancer of the right middle lobe 
Lymph node station 
Case T Detection 3a 1 2 3 4 7 10 11 12 13 
1 1 No 
2 1 No 
3 2 No 1 
4 1 Yes 1 
5 2 No 1 
6 1 No 5 
1 
4 1 
Data presented as in Table III. 
superior mediastinal compartment was present in 
one case. 
Table V shows the findings in 17 cases with 
mediastinal lymph node metastases from cancer of 
the right lower lobe. The surgeon could not detect 
the lymph node metastases in 15 cases. Seven cases 
were without a nodal metastasis n the lobar or hilar 
area (cases 1 through 5, 9, and 12). All cases but one 
had subcarinal ymph node metastases. One case 
had the metastases only in the inferior pulmonary 
nodes. 
Table V. Mediastinal lymph node metastases from 
cancer of the right lower lobe 
Lymph node station 
Case T Detection 1 2 3 4 7 8 9 10 11 12 13 
1 2 No 
2 2 No 1 
3 2 No 1 
4 1 No 1 
5 1 No 1 
6 1 No 1 
7 2 No 1 
8 2 No 1 
9 2 No 2 
10 1 No 2 
11 2 No 2 
12 3 Yes 2 2 2 
13 2 No 1 1 1 
14 2 No 2 2 4 
15 1 Yes 2 2 4 
16 1 No 2 4 4 
17 2 No 4 1 2 
1 2 
1 3 2 
2 1 
5 
2 2 2 
1 1 
Data presented as in Table III. 
Table VI shows the findings in 23 cases with 
mediastinal lymph node metastases from cancer of 
the left upper lobe. The surgeon could not detect 
the lymph node metastasis in 12 cases. Five cases 
were without a nodal metastasis n the lobar or hilar 
area (cases 4, 5, 8, 15, 18). All cases had the lymph 
node metastases in the subaortic ompartment. Sub- 
aortic nodes (station 5) had the most metastases of
all nodes. 
Data for 13 cases with mediastinal lymph node 
metastases from cancer of the left lower lobe are 
shown in Table VII. The surgeon could not detect 
the lymph node metastasis in 6 cases. Two cases 
were without a nodal metastasis n the lobar or hilar 
area (cases 4, 11). Twelve cases had lymph node 
metastases in the subcarinal area or subaortic om- 
partment. Two cases had the metastasis in the 
inferior pulmonary lymph node. 
Discussion 
There were 79 patients (14%) with N2 disease 
among our 575 patients with clinical stage I periph- 
eral NSCLC. The surgeon could not detect the 
lymph node metastasis n 54 patients (68%) with N2 
disease. Twenty-six patients with N2 disease were 
without a nodal metastasis n the lobar or hilar area, 
therefore lymph nodes showed a 33% rate of skip 
areas involving the mediastinum without involving 
the lobar area. Although some authors claim that 
radical systematic lymph node dissection should be 
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Table VI. Mediastinal lymph node metastases from 
cancer of the left upper lobe 
Lymph node station 
Case T Detection 4 5 6 7 10 11 12 13 
1 2 Yes 1 
2 1 No 1 
3 2 Yes 7 
4 2 No 1 
5 2 No 1 
6 2 Yes 1 
7 2 No 1 
8 1 No 1 1 
9 1 Yes 1 1 
10 2 Yes 2 
11 1 No 2 1 
12 1 Yes 2 1 
13 1 No 2 1 
14 2 Yes 2 2 
15 2 No 1 
16 1 No 1 
17 1 Yes 1 1 
18 2 No 1 2 
19 1 No 1 1 
20 3 Yes 1 1 1 
21 1 Yes 1 1 2 
22 2 No 1 5 5 
23 1 Yes 2 3 
1 1 
1 1 
2 
1 
2 1 
1 
1 2 
1 
2 
2 
2 1 
3 
Data presented as in Table In. 
done in all patients with resectable primary tu- 
mors, 34 the Lung Cancer Study Group recommends 
the sampling of mediastinal nodes at the time of 
surgical resection for lung cancer. 6 Izbiki and col- 
leagues 9 stated that systematic mediastinal lymph- 
adenectomy is not essential to determine the N 
stage, but results in a more detailed staging of the 
N2 region, which is of prognostic significance. The 
extent of lymphadenectomy in the mediastinum is 
still a matter of controversy. 
Our data indicated that the locations of the 
primary tumors corresponded to the mediastinal 
areas where lymph nodes were likely to be diseased 
and the nodal metastasis of a single station often 
occurred. When the tumor was located in the right 
upper lobe, the superior mediastinal compartment 
was the area where lymph nodes had the most 
metastases and the nodal metastasis of a single 
station occurred. When the tumor was in the right 
middle lobe, the subcarina nd anterior mediasti- 
num were the areas with like involvement. When the 
tumor was in the right lower lobe, the subcarina nd 
inferior mediastinum were the respective areas of 
involvement. When the tumor was in the left upper 
Table VII. Mediastinal ymph node metastases from 
cancer of the left lower lobe 
Lymph node station 
Case T Detection 4 5 6 7 8 9 10 11 12 13 
1 2 Yes 1 1 1 
2 3 No 1 1 
3 2 No 2 1 
4 1 No 2 1 
5 1 No 1 1 2 1 
6 2 Yes 1 1 1 
7 1 Yes 1 1 
8 2 Yes 1 2 1 3 3 
9 1 No 2 1 1 
10 2 No 1 1 2 
11 1 Yes 1 1 
12 2 Yes 1 1 1 2 1 1 
13 2 Yes 1 1 2 2 3 
Data presented as in Table III. 
lobe, the corresponding area was the subaortic 
compartment, and for tumor in the left lower lobe, it 
was the subcarina nd subaortic ompartment. We 
believe that lymphadenectomy should be the choice 
of surgical procedures in these mediastinal reas. 
On the other hand, our data indicated that the 
locations of the primary tumors corresponded to the 
mediastinal reas where lymph nodes were rarely 
positive, but when positive, always involved multiple 
nodes. When the tumor was located in the right or 
left upper lobe, the subcarina was the area where 
lymph nodes were rarely positive but when positive, 
always involved nodal diseases in multiple stations. 
When the tumor was in the right lower lobe, the 
superior mediastinal compartment was similarly in- 
volved as described for the upper lobes. We recom- 
mend sampling of lymph nodes in these mediastinal 
areas unless nodal disease is suspected in the medi- 
astinum. The Lung Cancer Study Group reported a
poor survival for patients with nodal disease in the 
subcarinal and any other mediastinal rea. 6When a 
nodal disease in the subcarinal rea is suspected in a 
patient with cancer of the right or left upper lobe, 
the surgical treatment must be considered carefully 
because apositive subcarinal node suggests multiple 
nodal involvement inthe mediastinum. When lymph 
node metastasis n the superior mediastinal com- 
partment is proved in a patient with cancer of the 
right lower lobe, surgical treatment may be useless 
because a positive node in the superior mediastinal 
compartment suggests multiple nodal disease in the 
mediastinum. 
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In  conclus ion,  systematic staging of mediast ina l  
lymph nodes is necessary for all pat ients  with resect- 
able clinical stage I lung cancer.  The  locat ion of the 
pr imary  tumor  determines  the mediast ina l  areas 
where  lymphadenectomy should be done to examine 
all lymph nodes.  
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